Site US00020 — Pittsburgh, Pennsylvania

Site US00020 is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site US00020 has participated in 1 clinical trials.

Therapeutic areas: Metastatic Urothelial Cancer and Other Malignant Solid Tumors.

Sponsors: Astellas Pharma Global Development, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pittsburgh

Browse all research sites in Pennsylvania · View every site in Pittsburgh

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US00020?

Site US00020 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US00020 conducted?

Site US00020 has 1 clinical trials on record. Their work covers Metastatic Urothelial Cancer and Other Malignant Solid Tumors.

Is Site US00020 accredited by Crixeo Clinical Trials?

Site US00020 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US00020?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.